DDL 2021

11 – 13 December 2021 | Format TBD

Proveris will sponsor this year’s Drug Delivery to The Lungs conference which will be held 11-13 December. Attendees to our exhibit will be able to explore new tools for spray characterization, studies for predictive in vitro / in vivo correlation, and precision automated actuation technology for through-life testing.

If you would like to learn more and schedule a meeting with us, email us at contactus@proveris.com.

Drug Delivery to the Lungs (DDL) is an annual conference covering all aspects of respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts. It offers a venue for lectures, posters and exhibitions.

Drug Delivery to the Lungs (DDL 2020)

9-11 December | Edinburgh, Scotland

Proveris is a Sponsor of Drug Delivery to the Lungs (DDL) 2020. We’ll showcase our latest technology solutions and laboratory services for Orally Inhaled and Nasal Drug Products (OINDPs). We’ll present study results in the Scientific Poster Session and host meetings in our private meeting room.

To schedule a meeting with us to discuss how we can help address your current challenges in OINDP development, email contactus@proveris.com.

DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

The Aerosol Society Website